Daiichi Sankyo teams up with US firm to develop biosimilars – Mainichi Daily News
Daiichi Sankyo teams up with US firm to develop biosimilarsMainichi Daily NewsDaiichi Sankyo will introduce relevant technology from Coherus BioSciences to develop biosimilar forms of etanercept for rheumatism treatment and rituximab for cancer treatme…
